Top Analyst Stocks
Up to the top 50 stocks backed by Wall Street’s most accurate analysts. A stock only makes this list when at least one analyst with a measured success rate of 70% or better holds a live price target on it, and the ranking combines how many of those analysts cover it, how accurate they have been, and the upside to the average of their targets. Informational, not investment advice.
Right now 149 stocks clear that bar, out of 190 carrying a live target from at least one of the 43 analysts above 70% on our leaderboard. The list grows as more of their calls season into a measured track record.
| # | Symbol | Company | Rating | Analysts | Avg target | Upside | Market cap |
|---|---|---|---|---|---|---|---|
| 1 | RKLB | Rocket Lab Corp | Buy | 26 | $105.17 | +99.9% | $33.63B |
| 2 | FTAI | FTAI Aviation Ltd. | Buy | 16 | $308.00 | +99.5% | $15.85B |
| 3 | IONS | IONIS PHARMACEUTICALS INC | Buy | 41 | $84.92 | +97.8% | $7.13B |
| 4 | APP | AppLovin Corp | Buy | 55 | $511.53 | +96.5% | $87.43B |
| 5 | AXSM | Axsome Therapeutics, Inc. | Buy | 54 | $283.00 | +95.1% | $7.60B |
| 6 | PHVS | Pharvaris N.V. | Buy | 22 | $60.73 | +93.3% | $2.21B |
| 7 | AMLX | Amylyx Pharmaceuticals, Inc. | Buy | 16 | $52.20 | +91.9% | $3.41B |
| 8 | AXTI | AXT INC | Buy | 14 | $99.50 | +91.0% | $3.42B |
| 9 | MIRM | Mirum Pharmaceuticals, Inc. | Buy | 45 | $153.20 | +90.6% | $5.22B |
| 10 | SMMT | Summit Therapeutics Inc. | Buy | 14 | $29.33 | +89.6% | $12.34B |
| 11 | DFTX | Definium Therapeutics, Inc. | Buy | 27 | $67.45 | +89.1% | $4.79B |
| 12 | VRT | Vertiv Holdings Co | Buy | 44 | $366.06 | +88.4% | $74.81B |
| 13 | LUCK | Lucky Strike Entertainment Corp | Buy | 13 | $7.80 | +86.6% | $569.85M |
| 14 | DOCN | DigitalOcean Holdings, Inc. | Buy | 30 | $172.82 | +85.4% | $10.96B |
| 15 | CYTK | CYTOKINETICS INC | Buy | 32 | $113.33 | +85.1% | $8.51B |
| 16 | AMBQ | Ambiq Micro, Inc. | Buy | 12 | $93.20 | +85.1% | $1.22B |
| 17 | ECG | Everus Construction Group, Inc. | Buy | 14 | $175.20 | +84.6% | $4.84B |
| 18 | ELVN | Enliven Therapeutics, Inc. | Buy | 14 | $76.29 | +83.7% | $3.04B |
| 19 | DNLI | Denali Therapeutics Inc. | Buy | 15 | $33.67 | +82.9% | $2.94B |
| 20 | TH | Target Hospitality Corp. | Buy | 11 | $25.20 | +82.7% | $1.35B |
| 21 | BABA | Alibaba Group Holding Ltd | Buy | 18 | $182.00 | +82.7% | $247.88B |
| 22 | PVLA | PALVELLA THERAPEUTICS, INC. | Buy | 27 | $228.50 | +82.7% | $1.80B |
| 23 | MU | MICRON TECHNOLOGY INC | Buy | 99 | $1588.85 | +81.1% | $992.88B |
| 24 | TSEM | TOWER SEMICONDUCTOR LTD | Buy | 10 | $302.00 | +80.2% | $19.02B |
| 25 | PTRN | Pattern Group Inc. | Buy | 14 | $29.00 | +79.1% | $2.87B |
| 26 | NVMI | NOVA LTD. | Buy | 14 | $556.50 | +78.7% | $9.90B |
| 27 | MNPR | Monopar Therapeutics | Buy | 12 | $126.00 | +78.3% | $474.21M |
| 28 | MTSI | MACOM Technology Solutions Holdings, Inc. | Buy | 24 | $415.71 | +76.0% | $18.04B |
| 29 | CLS | CELESTICA INC | Buy | 32 | $456.23 | +75.5% | $32.79B |
| 30 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Buy | 26 | $101.56 | +75.0% | $8.20B |
| 31 | MSTR | Strategy Inc | Buy | 32 | $255.36 | +74.9% | $61.85B |
| 32 | SEI | Solaris Energy Infrastructure, Inc. | Buy | 26 | $101.89 | +73.5% | $5.91B |
| 33 | LBRT | Liberty Energy Inc. | Buy | 34 | $27.00 | +73.2% | $2.54B |
| 34 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Buy | 18 | $132.60 | +72.7% | $4.29B |
| 35 | ENOV | Enovis CORP | Buy | 15 | $36.33 | +72.3% | $1.22B |
| 36 | SRRK | Scholar Rock Holding Corp | Buy | 23 | $71.30 | +71.8% | $5.05B |
| 37 | MAMA | Mama's Creations, Inc. | Buy | 12 | $22.00 | +71.6% | $604.43M |
| 38 | IRON | Disc Medicine, Inc. | Buy | 20 | $127.14 | +70.6% | $3.31B |
| 39 | PENN | PENN Entertainment, Inc. | Buy | 26 | $24.50 | +69.0% | $1.95B |
| 40 | LSCC | LATTICE SEMICONDUCTOR CORP | Buy | 28 | $162.14 | +68.6% | $13.66B |
| 41 | COGT | Cogent Biosciences, Inc. | Buy | 12 | $51.75 | +65.8% | $5.42B |
| 42 | CAVA | CAVA GROUP, INC. | Buy | 53 | $88.28 | +65.1% | $6.25B |
| 43 | GENI | Genius Sports Ltd | Buy | 27 | $10.44 | +64.9% | $1.69B |
| 44 | EQPT | EquipmentShare.com Inc | Buy | 19 | $26.33 | +64.5% | $4.06B |
| 45 | VSTM | Verastem, Inc. | Buy | 14 | $16.43 | +63.6% | $909.26M |
| 46 | NVT | nVent Electric plc | Buy | 33 | $203.86 | +62.6% | $20.30B |
| 47 | BETA | BETA Technologies, Inc. | Buy | 12 | $32.00 | +61.6% | $4.63B |
| 48 | AVGO | Broadcom Inc. | Buy | 51 | $514.37 | +59.9% | $1.54T |
| 49 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Buy | 14 | $13.44 | +58.7% | $3.78B |
| 50 | DOMO | Huckleberry.ai, Inc. | Buy | 12 | $3.89 | +9.6% | $360.00M |
Every analyst with a price target on file over the trailing year, not a starred subset. A stock appears when at least 10 analysts cover it, the consensus is buy-rated, and the average target is above the current price; rows are ranked by that room. Informational, not investment advice.
Success rates are measured from each analyst’s own past price targets — the share of their seasoned calls (30 days or older) that moved in the direction the target implied — so only analysts with a real track record can put a stock on this list. Targets older than a year are treated as history, not live coverage. Upside is the move from the current price to the covering analysts’ average target. Informational, not investment advice.